首页> 外文会议>ESA Annual Meeting on Electrostatics >Enhanced Drug Uptake in Normal and Malignant Breast Cell Lines Using Electrical Pulses
【24h】

Enhanced Drug Uptake in Normal and Malignant Breast Cell Lines Using Electrical Pulses

机译:使用电脉冲增强正常和恶性乳房细胞系中的药物吸收

获取原文

摘要

Conventional breast cancer treatments, such as surgery (the Gold Standard), radiation therapy and chemotherapy serve most of the patients while they do not serve all of them. They are expensive and have extensive side effects, both near term and long term. Affordable, alternate treatments are needed to treat aggressive and drug resistant breast cancer tumors. We propose the use of electrical pulses to enhance the therapeutic molecule uptake in breast cancer patients. In order to better understand uptake processes of malignant tissues, it is necessary to investigate uptake in normal tissues as a reference. In this research, we studied the different electroporation characteristics of malignant breast cancer cell lines, MCF-7 and CRl 1743 compared to the non-malignant breast cancer cell lines MCF-10. We applied 200 V/cm, 10-40 ms pulses and studied their effect on viability and other phenomena. Considering that approximately one million incidences of breast cancers are estimated in the world, with ~200,000 in the US and ~320,000 in the Europe, and the rest in the rest of the world, inexpensive, less toxic, existing alternative treatments need to be developed and implemented for clinical practice.
机译:常规的乳腺癌治疗,如手术(金标准),放射治疗和化疗的大部分患者,而他们不为所有患者提供所有患者。它们是昂贵的,并且具有广泛的副作用,近期和长期。经济实惠的,需要替代治疗来治疗侵袭性和耐药性乳腺癌肿瘤。我们提出使用电脉冲来增强乳腺癌患者的治疗分子吸收。为了更好地了解恶性组织的摄取过程,有必要在正常组织中进行摄取作为参考。在本研究中,与非恶性乳腺癌细胞系MCF-10相比,我们研究了恶性乳腺癌细胞系,MCF-7和CRL 1743的不同电穿孔特性。我们施加了200 v / cm,10-40毫升脉冲,并研究了对生存能力和其他现象的影响。考虑到世界上估计大约一百万次乳腺癌发生乳腺癌,在美国〜200,000次,欧洲〜320,000人,剩下的世界中廉价,毒性较少,需要开发现有的替代治疗并实施临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号